Literature DB >> 8274614

Infections with Aspergillus species.

V T Andriole1.   

Abstract

Invasive aspergillosis is a common infection in patients who are immunocompromised. The diagnosis of invasive aspergillosis is difficult in the absence of confirmation by tissue biopsy and histological studies. Therefore, recent advances that may be important for the development of highly sensitive and specific serodiagnostic tests for the early diagnosis of invasive aspergillosis are reviewed. The inability of the detection of antibody to Aspergillus to lead to early diagnosis of invasive aspergillosis also is emphasized. However, sensitive methods that reliably detect significant amounts of aspergillus antigen in body fluids of high-risk patients are currently being evaluated and may provide a noninvasive early diagnostic test that is both sensitive and specific. Also, current antifungal agents with anti-aspergillus activity that have potential as therapeutic or prophylactic agents are reviewed briefly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274614     DOI: 10.1093/clinids/17.supplement_2.s481

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.

Authors:  Ray Hachem; Paul Bahna; Hend Hanna; L Clifton Stephens; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide.

Authors:  S Y Hong; J E Oh; K H Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.

Authors:  E K Manavathu; J R Dimmock; S C Vashishtha; P H Chandrasekar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis.

Authors:  S F Hurst; G H Reyes; D W McLaughlin; E Reiss; C J Morrison
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection.

Authors:  A C Leenders; A van Belkum; M Behrendt; A Luijendijk; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Aspergillus spp. seropositivity in New Zealand penguins.

Authors:  T K Graczyk; J F Cockrem
Journal:  Mycopathologia       Date:  1995-09       Impact factor: 2.574

9.  Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward.

Authors:  A Leenders; A van Belkum; S Janssen; S de Marie; J Kluytmans; J Wielenga; B Löwenberg; H Verbrugh
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

10.  Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus.

Authors:  M E Brandt; A A Padhye; L W Mayer; B P Holloway
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.